What caused the drop in Charmacy Pharmaceutical stock?

The drop in Charmacy Pharmaceutical stock could be due to sector weaknesses or company-specific issues, amplified by low trading volumes and market volatility.

What are the key technical indicators to watch?

Key indicators include the RSI at 28.45, indicating oversold conditions, and support at the lower Bollinger Band around HK$5.05, which could be pivotal for a bounce.

How does Meyka AI rate Charmacy Pharmaceutical?

Meyka AI rates the stock with a score of 71.69, assigning a B+ grade and a BUY recommendation, based on various market and financial conditions analyses.

What is the stock's debt situation?

The company has a debt-to-equity ratio of 1.78, indicating high leverage, which poses risks especially in a volatile market environment. However, it maintains a strong dividend yield to attract investors.

What is the forecasted price for Charmacy in the near term?

Meyka AI projects a potential price recovery to HK$6.74, an upside of 31.42% from the current level of HK$5.13. However, such forecasts are projections and not guarantees.

HK Stocks

2289.HK Drops -17.39%: Key Levels in Focus

ByHuzaifa Zahoor December 28, 2025December 28, 2025

Charmacy Pharmaceutical Co., Ltd. (2289.HK) witnessed a steep decline of -17.39%, closing at HK$5.13. This article explores the underlying factors leading to this drop and examines key support levels to watch for potential recovery scenarios.